rs374935079
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_017570.5(OPLAH):c.1424C>T(p.Ala475Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000154 in 1,610,798 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017570.5 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 22AN: 152250Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000197 AC: 47AN: 238996 AF XY: 0.000191 show subpopulations
GnomAD4 exome AF: 0.000155 AC: 226AN: 1458548Hom.: 0 Cov.: 35 AF XY: 0.000165 AC XY: 120AN XY: 725380 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000144 AC: 22AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
The OPLAH p.Ala475Val variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs374935079) and in control databases in 51 of 270388 chromosomes at a frequency of 0.0001886 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 46 of 122142 chromosomes (freq: 0.000377), Other in 2 of 6946 chromosomes (freq: 0.000288), African in 1 of 23074 chromosomes (freq: 0.000043), European (Finnish) in 1 of 24144 chromosomes (freq: 0.000041) and Latino in 1 of 34818 chromosomes (freq: 0.000029), but was not observed in the Ashkenazi Jewish, East Asian, or South Asian populations. The p.Ala475 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. However, this has not been confirmed by RNA analysis and is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
OPLAH: PM2 -
not specified Uncertain:1
The c.1424C>T (p.A475V) alteration is located in exon 11 (coding exon 10) of the OPLAH gene. This alteration results from a C to T substitution at nucleotide position 1424, causing the alanine (A) at amino acid position 475 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
5-Oxoprolinase deficiency Uncertain:1
This sequence change replaces alanine with valine at codon 475 of the OPLAH protein (p.Ala475Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs374935079, ExAC 0.05%). This variant has not been reported in the literature in individuals with OPLAH-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Possibly Damaging; Align-GVGD: Class C0). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at